R. Manduke

Dana-Farber Cancer Institute US

Publications

Citations

H-Index

i10-Index

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Personnel environmental monitoring during manufacture of manipulated cell therapy products

H. Negre, L. Pinte, R. Manduke, A. Cunningham, H. Anderson - Unknown Venue, 2018

Cited by 4 Semantic Scholar

Safety considerations in the generation of clinical grade autologous ips cell lines

H. Anderson, L. Daheron, G. Savvidis, H. Negre, Anwesha Nag - Unknown Venue, 2018

Cited by 0 Semantic Scholar

Phase I Trial of Regulatory T-Cell Donor Lymphocyte Infusion Plus Daily Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Versus-Host Disease

S. Nikiforow, Haesook T. Kim, Kyle T. Jones, Jeremy G. Stewart, H. Garrity - Unknown Venue, 2017

Cited by 3 Semantic Scholar

Research Topics

Mesenchymal stem cell research (1) Hematopoietic Stem Cell Transplantation (1) Pluripotent Stem Cells Research (1) Pancreatic function and diabetes (1) CRISPR and Genetic Engineering (1)

Affiliations

Dana-Farber Cancer Institute

US 2018 - 2017

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers

R. Manduke

Publication & Citation Trends

Publications

Personnel environmental monitoring during manufacture of manipulated cell therapy products

Safety considerations in the generation of clinical grade autologous ips cell lines

Phase I Trial of Regulatory T-Cell Donor Lymphocyte Infusion Plus Daily Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Versus-Host Disease

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back